Medically reviewed by Abu Koroma, PMHNP-BC, CRNA · Supply status verified August 7, 2026 · 11 min read
KEY FACTS
| When it started | October 2022, when the largest U.S. manufacturer of generic amphetamine mixed salts reported manufacturing and packaging delays |
| How long it has run | More than three years, spreading from one product to multiple manufacturers, formulations, and dose strengths |
| Methylphenidate added | July 2023 — a related but separate shortage from the amphetamine one |
| What changed recently | DEA raised production quotas roughly 25% in October 2025 and released 2026 quotas on January 5, 2026, setting d,l-amphetamine at 24,234,443 grams |
| The safety warning | DEA lab testing finds 5 of every 10 counterfeit pills containing fentanyl carry a potentially lethal dose. Counterfeit “Adderall” is specifically targeted by traffickers |
| Contact | Medication management in York or call (717) 202-2285 · 111 East Market Street, Suite 201, York, PA 17401 |

You have probably done the loop already. The pharmacy is out. They cannot say when more is coming. They cannot transfer the prescription because it is a Schedule II. And your prescriber’s office is closed until Monday.
This article is about the logistics of that problem — the supply picture, the pharmacy workflow that actually works, and the safety issue nobody warns patients about loudly enough. It is not a guide to ADHD treatment or diagnosis; those live on the ADHD service page and in our online ADHD treatment in Pennsylvania overview.
Why the shortage persists
Two systems have to line up before a stimulant reaches a pharmacy shelf, and they operate on completely different clocks.
The DEA quota system. Stimulants are Schedule II, so the DEA sets an annual aggregate production quota capping how much of each controlled ingredient may be manufactured nationwide, then allocates portions to individual manufacturers. If a company hits its allocation, it stops — regardless of demand. The DEA raised quotas roughly 25% in October 2025, and on January 5, 2026 released the 2026 quotas, setting d,l-amphetamine at 24,234,443 grams, about 14% above the originally proposed figure after more than 5,000 public comments. Lisdexamfetamine was raised substantially as well.
Manufacturing reality. Quotas set a ceiling, not a floor. A manufacturer still has to source ingredient, run lines, and get product through packaging — and the original 2022 disruption was a packaging problem, not a quota problem. Companies also choose which strengths to prioritize, which is why a low-dose tablet may sit on a shelf while the strength you need is nowhere in the county.
Add sustained demand growth on top and you get the pattern patients actually experience: not a clean shortage, but a patchwork. Some products fill without trouble; others vanish for weeks and reappear without warning.
Where supply stands — and how to check it yourself
Read this table as a starting point, not a verdict. Supply status changes week to week and varies by region, pharmacy chain, and dose strength. The authoritative live sources are the FDA Drug Shortage Database and the ASHP shortage list. Neither replaces a phone call to your actual pharmacy.
| Medication class | Status as of August 2026 | What to ask your prescriber |
|---|---|---|
| Amphetamine mixed salts, generic (IR and XR) | Still listed in active shortage. Generic immediate-release and mid-range XR strengths are the hardest to find | Whether a different strength combination could reach the same daily dose |
| Methylphenidate, generic (incl. ER) | On the FDA shortage list since July 2023; improved from the 2023–24 low point but still inconsistent by strength | Whether the brand version is stocked when the generic is not |
| Lisdexamfetamine | Brand generally available; generic supply spotty. DEA raised its 2026 quota substantially | Whether it is a clinically appropriate option for you, and what your plan covers |
| Other stimulant formulations | Patches, orally disintegrating tablets, liquid suspensions, and long-acting variants have separate supply chains and are often stocked when standard products are not | Whether any same-class alternative formulation is appropriate for your situation |
| Non-stimulants | Not controlled substances, so not subject to DEA quotas — generally the most reliably available category | Whether a non-stimulant is a reasonable fit, and how long it takes to know |
Every entry in that last column is a question, not a recommendation. Which medication is right for you depends on your history, other conditions, and what you have already tried — not on what happens to be in stock. Do not switch or stop anything on your own because of a supply headline.
The pharmacy workflow that actually works
Most gaps in treatment are logistics failures, not supply failures. The order of operations matters enormously.
- Call before the prescription is sent, not after. This is the whole trick. Federal rules do not allow the routine transfer of Schedule II prescriptions between pharmacies, so once a script lands it is hard to move. Call around first, find a pharmacy holding your exact medication and strength, then tell your prescriber where to send it.
- Ask a precise question. Not “do you have Adderall?” but “do you have [medication], [strength], [immediate or extended release], and how many tablets are on the shelf right now?” Quantity matters — a pharmacy with nine tablets cannot fill a thirty-day script.
- Ask about a partial fill. Federal rules permit partial filling of a Schedule II prescription at the patient’s or prescriber’s request, with the balance dispensed within a defined window. Not every pharmacy volunteers this. Ask directly — a partial fill of ten days now beats zero days now.
- Never let a script sit at a store that cannot fill it. If a pharmacy is holding your prescription and cannot give you a date, call your prescriber and ask them to cancel it there and reissue elsewhere. A prescription sitting unfilled is worse than no prescription, because it blocks you from filling anywhere else.
- Start the refill cycle early. Build a buffer of several days so one out-of-stock pharmacy does not immediately become a missed dose.
- Stay with a pharmacy that reliably stocks you. Pharmacies order on their own dispensing history. A store that fills you every month has a reason to keep your product in inventory; a store you visit once does not.
- Independent pharmacies are worth trying. They order through different wholesalers than the large chains and are often able to source products the chains cannot. York County has several.
The ADHD stimulant shortage has now run for more than three years — beginning in October 2022 with a single manufacturer’s packaging delay and expanding across manufacturers, formulations, and dose strengths. It is the longest-running shortage of a widely prescribed psychiatric medication class in recent memory.

The counterfeit pill warning
DEA laboratory testing finds that 5 of every 10 counterfeit pills containing fentanyl carry a potentially lethal dose. Counterfeit pills are mass-produced to look identical to real prescription medication — and “Adderall” is specifically among the products traffickers imitate, precisely because demand outstrips legitimate supply. In 2025 alone the DEA seized more than 47 million fentanyl-laced counterfeit pills. A pill that looks right, is stamped right, and comes from someone you trust can still kill you.
This is the part of the shortage story that gets the least attention and matters most. When a legitimate supply chain fails, an illegitimate one fills the gap — with no quality control, no dosing consistency, and no accountability.
The CDC has issued a health advisory specifically about disrupted access to prescription stimulants and the associated risk of injury and overdose, noting that patients who lose access to prescribed treatment may turn to sources outside the regulated supply chain. If you are running out and cannot get filled, the correct move is to call your prescriber — not to find another way to get pills.
Borrowing someone else’s prescription carries its own problems even when the medication is genuine: wrong dose, wrong formulation, no monitoring — and in Pennsylvania, a criminal offense for both parties.
What to ask your prescriber about
Bring these to your next appointment rather than waiting until you are out.
- Same-class alternative formulations. Within one medication family there are often patch, liquid, orally disintegrating, and different long-acting versions, each with its own supply chain. One may be stocked when another is not. Whether any is appropriate is your prescriber’s call.
- Strength arithmetic. If your usual strength is unavailable, a different combination of available strengths may reach the same daily dose. This is a prescriber decision, never a do-it-yourself adjustment.
- A documented backup. Ask whether it makes sense to have a second option agreed in advance, so that a stockout triggers a phone call rather than a new appointment.
- Prior authorization, before you need it. Many plans require it for alternatives and the process takes days. Ask whether it can be started proactively, and whether documented shortage supports a non-preferred agent.
- Timing of the next prescription. Know exactly when in your cycle a new prescription can be issued, so you can start calling pharmacies before the last few days.
Ongoing prescribing, dose adjustment, and this kind of contingency planning are what medication management in York visits are for. One related item worth knowing about: federal telehealth flexibilities that allow controlled medications to be prescribed by video without a prior in-person exam are currently set to expire at the end of this year — see our explainer on the December 31, 2026 telehealth prescribing deadline.
Contingency planning built into your visits, so a stockout is a phone call and not a crisis.
Serving patients across York County
Related reading
The December 31, 2026 telehealth prescribing deadline
What patients on controlled medications need to know.
504 plans and IEPs for ADHD in Pennsylvania schools
What your provider can document, and how the process works.
How long does it take to see a psychiatrist in York County?
The real wait times, and four levers that shorten them.
Frequently asked questions
Is there still an Adderall shortage in 2026?
Yes, though it has eased. As of August 2026 the FDA and ASHP still list amphetamine mixed salts in active shortage, more than three years after it began in October 2022. Generic immediate-release versions and certain extended-release strengths remain hardest to find. Availability varies by strength, manufacturer, and individual pharmacy rather than being uniformly unavailable.
Why can’t my pharmacy transfer my stimulant prescription somewhere else?
Stimulants are Schedule II controlled substances, and federal rules do not permit the routine transfer of Schedule II prescriptions between pharmacies the way they do for other medications. That is why calling to confirm stock before the prescription is sent matters so much. If a script is stuck at a pharmacy that cannot fill it, ask your prescriber to cancel it there and reissue it elsewhere.
Can I get a partial fill if the pharmacy only has some of my prescription?
Often yes. Federal rules allow a Schedule II prescription to be partially filled at the request of the patient or the prescriber, with the remainder dispensed within a defined window. Not every pharmacy offers this without being asked, so raise it directly. A partial fill covering ten days is considerably better than leaving with nothing.
What should I do if I run out before I can get a refill?
Call your prescriber the same day rather than waiting. Do not adjust your own dose to stretch a supply, and do not obtain medication from any source other than a licensed pharmacy. Your prescriber may be able to reissue to a different pharmacy, arrange a partial fill, or discuss an alternative. Stopping abruptly should be a clinical decision, not an accident.
Why is buying ADHD medication online dangerous?
Because counterfeit pills are mass-produced to look identical to real medication and frequently contain fentanyl. DEA laboratory testing finds that 5 of every 10 counterfeit pills containing fentanyl carry a potentially lethal dose, and counterfeit “Adderall” is among the products traffickers specifically imitate. There is no way to identify a counterfeit by appearance. Only a licensed pharmacy is safe.
Are non-stimulant ADHD medications affected by the shortage?
Generally no. Non-stimulant medications are not controlled substances, so they are not subject to DEA production quotas and have been the most reliably available category throughout the shortage. Whether one is an appropriate option depends on your clinical picture and how quickly you need an effect, which is a conversation to have with your prescriber rather than a substitution to make on your own.

People also ask
What causes ADHD medication shortages?
Two systems have to align. The DEA caps how much controlled ingredient may be produced nationwide each year and allocates it among manufacturers, so a company that reaches its allocation stops producing regardless of demand. Separately, manufacturers face ingredient sourcing, production, and packaging constraints, and choose which strengths to prioritize. Sustained demand growth compounds both.
How do I find a pharmacy that has my medication in stock?
Call rather than relying on any website, and ask a precise question: the medication, the exact strength, immediate or extended release, and how many units are physically on the shelf. Independent pharmacies order through different wholesalers than large chains and are worth including. Confirm stock before your prescriber sends the prescription, not afterward.
Will the ADHD medication shortage end in 2026?
There is no announced end date. DEA quota increases in October 2025 and January 2026 have improved conditions, and additional manufacturers have entered the market, but supply has not fully caught up with demand. Most observers expect gradual improvement rather than a defined resolution. Because status changes week to week, the live FDA and ASHP shortage lists are the only reliable check.
Psychiatric medication management in York, in person or by secure video across Pennsylvania, Maryland, and Virginia. We accept all major insurances. Call today to confirm your insurance. (717) 202-2285.
Sources
- U.S. Food and Drug Administration — Drug Shortage Database (live).
- U.S. Food and Drug Administration — Drug Shortages overview.
- American Society of Health-System Pharmacists — Amphetamine extended-release oral presentations shortage detail.
- CDC Health Alert Network — Health advisory on disrupted access to prescription stimulant medications.
- U.S. Drug Enforcement Administration — One Pill Can Kill (counterfeit pill data and seizure figures).
- DEA Get Smart About Drugs — counterfeit pill laboratory testing findings.
- U.S. Drug Enforcement Administration — 2026 Aggregate Production Quotas, released January 5, 2026.
Medically reviewed by
Abu Koroma is a board-certified psychiatric mental health nurse practitioner and a U.S. Army Reserve veteran. He treats patients ages 12 and older by telehealth across Pennsylvania, Maryland, and Virginia, with a focus on veterans, first responders, and men’s mental health.
This article describes medication supply conditions as verified on August 7, 2026 and is general information, not medical advice. Drug shortage status changes frequently and varies by region and pharmacy; check the live FDA and ASHP listings. Never start, stop, change, or stretch a prescribed medication in response to a supply article — talk to your prescriber. Obtain medication only from a licensed pharmacy. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline) or call 911 for emergencies. Veterans: call 988 and press 1. Optimal Health York is an independent psychiatric and primary care practice at 111 East Market Street, Suite 201, York, PA 17401.